Frequency of TERT promoter mutations in human cancers

Vinagre, João, Almeida, Ana, Pópulo, Helena, Batista, Rui, Lyra, Joana, Pinto, Vasco, Coelho, Ricardo, Celestino, Ricardo +16 more·2013·Nature Communications

DOI 10.1038/ncomms3185

Cited by (886)

Items 501–600 of 886

TERTp Mutation Detection in Plasma by Droplet-Digital Polymerase Chain Reaction in Spinal Myxopapillary Ependymoma with Lung Metastases
Anne Deniel, Florent Marguet, Ludivine Beaussire, A.C. Tobenas-Dujardin, Christophe Peillon, Marco-Achille Gambirasio, Ovidiu Veresezan, Nicolas Magne, Frédéric Di Fiore, Annie Laquerrière et al. · 2019 · World Neurosurgery
Detection of TERT Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error
Hyunwoo Lee, Boram Lee, Deok Geun Kim, Yoon Ah Cho, Jung-Sun Kim, Yeon‐Lim Suh · 2021 · Cancer Research and Treatment
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors
Flavio Mavignier Cárcano, Daniel Onofre Vidal, André van Helvoort Lengert, Cristovam Scapulatempo‐Neto, Luísa Queiroz, Herlander Marques, Fátima Baltazar, Camila Maria da Silva Martinelli, Paula Soares, Eduardo Caetano Albino da Silva et al. · 2015 · Tumor Biology
The genomic landscape of papillary thyroid carcinoma
Massimo Mattia Santoro, Rosa Marina Melillo · 2014 · Nature Reviews Endocrinology
hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality
Yingbo Lin, Nelly Seger, Yi Chen, Asle Charles Hesla, Johan Wejde, Mehran Ghaderi, Panagiotis Tsagkozis, Olle Larsson, Felix Haglund · 2018 · Modern Pathology
Avoiding New Biopsies by Identification of IDH1 and TERT Promoter Mutation in Nondiagnostic Biopsies From Glioma Patients
Marc Barritault, Thiébaud Picart, Delphine Poncet, Tanguy Fenouil, A. d’Hombres, Mathieu Gabut, Jacques Guyotat, Emmanuel Jouanneau, Roxana Améli, Bastien Joubert et al. · 2020 · Neurosurgery
TERT Promoter Mutational Analysis as an Ancillary Diagnostic Tool for Diagnostically Challenging Melanocytic Neoplasms
Anastasiya Boutko, Sepideh Nikki Asadbeigi, Andrew Roth, Nathaniel Lampley, Shantel Olivares, David Dittmann, David Dittmann, Lawrence J. Jennings, Pedram Gerami · 2023 · American Journal of Dermatopathology
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
Julie Delyon, A. Vallet, Mélanie Bernard-Cacciarella, Isabelle Kuzniak, Coralie Reger de Moura, Baptiste Louveau, Fanélie Jouenne, Samia Mourah, Célèste Lebbé, Nicolas Dumaz · 2023 · Cancers
TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
Gustavo Penna, Ana Pestana, José Manuel Cameselle, Denise Momesso, Fernanda Accioly de Andrade, Ana Paula Aguiar Vidal, Mário Lúcio Cordeiro Araújo, Miguel Melo, Priscila Valverde Fernandes, Rossana Corbo et al. · 2018 · Endocrine
Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers
Zhaoming Wang, Stephen V. Rice, Ti‐Cheng Chang, Yu Liu, Qi Liu, Na Qin, Daniel K. Putnam, Kyla Shelton, Jennifer Q. Lanctot, Carmen Louise Wilson et al. · 2019 · JNCI Journal of the National Cancer Institute
Genetic characterisation of sarcomatoid carcinomas reveals multiple novel actionable mutations and identifies KRAS mutation as a biomarker of poor prognosis
Ying Ding, Yang Washington Shao, Chenglong Na, Jiani C. Yin, H J Hua, Ran N. Tao, Yue Jiang, Ran Hu, Xiaodong He, Miao Chen et al. · 2020 · Journal of Medical Genetics
Clinicopathological Implications of the BRAFV600E Mutation in Papillary Thyroid Carcinoma of Ukrainian Patients Exposed to the Chernobyl Radiation in Childhood: A Study for 30 Years After the Accident
Liudmyla Yu. Zurnadzhy, Bogdanova Ti, Tatiana Rogounovitch, Masahiro Ito, Mykola D. Tronko, Shunichi Yamashita, Norisato Mitsutake, Michael Bolgov, S.V. Chernyshov, Sergii V. Masiuk et al. · 2022 · Frontiers in Medicine
Molecular testing in fine‐needle aspiration of thyroid nodules
Valarie McMurtry, Şule Canberk, Georgios Deftereos · 2022 · Diagnostic Cytopathology
Argininosuccinate lyase drives activation of mutant TERT promoter in glioblastomas
Zhumei Shi, Xin Quan Ge, Mengdie Li, Jianxing Yin, Xiefeng Wang, Junxia Zhang, Dongyin Chen, Xinjian Li, Xiuxing Wang, Jing Ji et al. · 2022 · Molecular Cell
Biology and genetics of acquired and congenital melanocytic naevi
Nigel Gordon Maher, Richard A. Scolyer, Andrew J. Colebatch · 2022 · Pathology
Leveraging sequences missing from the human genome to diagnose cancer
Ilias Georgakopoulos‐Soares, Ofer Yizhar Barnea, Ioannis Mouratidis, Candace S. Y. Chan, Michail Patsakis, Akshatha Nayak, Rachael Bradley, Mayank Mahajan, Jasmine Sims, Dianne Laboy Cintrón et al. · 2025 · Communications Medicine
Differentiated thyroid cancer in patients with resistance to thyroid hormone syndrome. A novel case and a review of the literature
João Vinagre, Fátima Borges, Alexandre Marconi de Souza Da Costa, Maria Inês Alvelos, Gláucia Maria Ferreira da Silva Mazeto, Manuel A. Sobrinho-Simões, Paula Soares · 2014 · Frontiers in Molecular Biosciences
TERT Promoter Mutations in Soft Tissue Sarcomas
Nathália Cristina Campanella, Valter Penna, Lucas Faria Abrahão‐Machado, Adriana Cruvinel‐Carloni, Guilherme Ribeiro, Paula Soares, Cristovam Scapulatempo‐Neto, Rui Manuel Reis · 2015 · The International Journal of Biological Markers
Prognostic Stratification of GBMs Using Combinatorial Assessment of IDH1 Mutation, MGMT Promoter Methylation, and TERT Mutation Status: Experience from a Tertiary Care Center in India
Suvendu Purkait, Supriya Mallick, Vikas Sharma, Anupam Kumar, Pankaj Pathak, Prerana Jha, Ahitagni Biswas, Pramod Kumar Julka, Deepak Kumar Gupta, Ashish Suri et al. · 2016 · Translational Oncology
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast
Felipe Correa Geyer, Kathleen A. Burke, Salvatore Piscuoglio, Charlotte K.Y. Ng, Anastasios D. Papanastasiou, Caterina Marchiò, Pier Selenica, Marcia Edelweiss, Melissa P. Murray, Edi Brogi et al. · 2017 · Molecular Oncology
Telomere Maintenance in Pediatric Cancer
Sandra Ackermann, Matthias Fischer · 2019 · International Journal of Molecular Sciences
The role of noncoding mutations in blood cancers
Sunniyat Rahman, Marc R. Mansour · 2019 · Disease Models & Mechanisms
Comprehensive Assessment of TERT mRNA Expression across a Large Cohort of Benign and Malignant Thyroid Tumours
Ana Pestana, Rui Batısta, Ricardo Celestino, Şule Canberk, Manuel A. Sobrinho-Simões, Paula Soares · 2020 · Cancers
An Evolutionary Genetic Perspective on Cancer Biology
Max Shpak, Jie Lu · 2016 · Annual Review of Ecology Evolution and Systematics
TERRA Gene Expression in Gastric Cancer: Role of hTERT
Sogand Vahidi, Ali Akbar Samadani · 2021 · Journal of Gastrointestinal Cancer
The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma
Tianze Liu, Long Qian, Luting Li, Hairun Gan, Xinyan Hu, Haoyu Long, Lukun Yang, Pengfei Pang, Siyang Wang, Wuguo Deng · 2021 · Molecular Therapy — Oncolytics
The Potent and Paradoxical Biology of Cellular Senescence in Cancer
Paul Bernard Romesser, Scott W. Lowe · 2023 · Annual Review of Cancer Biology
Links between telomere dysfunction and hallmarks of aging
Sheng Li, Zhihao Liu, Jing Zhang, Lan Li · 2023 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
Genomics-Enabled Precision Medicine for Cancer
Alison Roos, Sara Ann Byron · 2019 · Cancer treatment and research
Molecular Characterization of Muellerian Tumors of the Urinary Tract
Nadina Ortiz‐Brüchle, Sophie Wucherpfennig, Michael Rose, Stefan Garczyk, Simone Bertz, Arndt Hartmann, Henning Reis, Tibor Szarvas, András Kiss, Felix Bremmer et al. · 2021 · Genes
Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
Xi Zheng, Felix Wezel, Anca Azoitei, Sabine Meessen, Wenya Wang, Gregoire Najjar, Xue Wang, Johann Michael Kraus, Hans Armin Kestler, Axel John et al. · 2021 · Cancers
Regulation of Gene Expression by Telomere Position Effect
Kyung‐Ha Lee, Do‐Yeon Kim, Wanil Kim · 2021 · International Journal of Molecular Sciences
Genomic Landscape, Clinical Features and Outcomes of Non-Small Cell Lung Cancer Patients Harboring BRAF Alterations of Distinct Functional Classes
Alessandro Di Federico, Andrea De Giglio, Francesco Gelsomino, Dario de Biase, Francesca Giunchi, Arianna Palladini, Francesca Sperandi, Barbara Melotti, Andrea Ardizzoni · 2022 · Cancers
The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR
Jinbo Liu, Zhihua Zhao, Miaomiao Sun, Kuisheng Chen, Weitang Yuan, Guozhong Jiang · 2016 · Genetic Testing and Molecular Biomarkers
Low frequency of TERT promoter mutations in a series of well-differentiated follicular-patterned thyroid neoplasms
Agnese Proietti, Chiara Sartori, Elisabetta Macerola, Nicla Borrelli, Gabriele Materazzi, Paolo Vitti, Fulvio Basolo · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression
Jaskaren S. Kohli, Hira Mir, Afsheen Wasif, Heung Chong, Victoria Akhras, Rajiv Kumar, Eduardo Nagore, Dorothy C. Bennett · 2017 · Oncotarget
When the Ends Are Really the Beginnings: Targeting Telomerase for Treatment of GBM
Saumya Bollam, Michael E. Berens, Harshil Dhruv · 2018 · Current Neurology and Neuroscience Reports
Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis
Zi-Xian Ma, Chunmei Yang, Mengge Li, Hong Tu · 2019 · Hepatoma Research
TERT Promoter Mutations Increase Sense and Antisense Transcription from the TERT Promoter
François Hafezi, Lisa Jaxel, Morgane Lemaire, Jonathan D. Turner, Danielle Perez-Bercoff · 2021 · Biomedicines
Immune‐related interaction perturbation networks unravel biological peculiars and clinical significance of glioblastoma
Zaoqu Liu, Yudi Xu, Yuhui Wang, Siyuan Weng, Hui Xu, Yuqing Ren, Chunguang Guo, Long Liu, Zhenyu Zhang, Xinwei Han · 2023 · iMeta
Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach
Sraddhya Roy, Ananya Das, Aparajita Bairagi, Debangshi Das, Ashna Jha, Amit Kumar Srivastava, Nabanita Chatterjee · 2024 · Mutation Research/Reviews in Mutation Research
TERT Alterations in Progressive Treatment-Resistant Meningiomas
Tareq Adnan Juratli, Priscilla Kaliopi Brastianos, Daniel P. Cahill · 2018 · Neurosurgery
Poly(U) binding splicing factor 60 promotes renal cell carcinoma growth by transcriptionally upregulating telomerase reverse transcriptase
Long Qian, Yi‐Jun Hua, Liru He, Changlin Zhang, Silei Sui, Yixin Li, Huijuan Qiu, Tian Tian, Xin An, Guangyu Luo et al. · 2020 · International Journal of Biological Sciences
The Regulation of ROS‐ and BECN1‐Mediated Autophagy by Human Telomerase Reverse Transcriptase in Glioblastoma
Xuelu Ding, Ziyang Nie, Zhaoyuan She, Xue Bai, Qiuhui Yang, Feng Wang, Fei Wang, Xin Geng · 2021 · Oxidative Medicine and Cellular Longevity
Toward urinary cell-free DNA-based treatment of urothelial carcinoma: a narrative review
Yujiro Hayashi, Kazutoshi Fujita · 2021 · Translational Andrology and Urology
LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth
Gavin R. Oliver, Sofia Marcano-Bonilla, Jonathan Quist, Ezequiel J. Tolosa, Eriko Iguchi, Amy A. Swanson, Nicole L. Hoppman, Tanya L. Schwab, Ashley N. Sigafoos, Naresh Prodduturi et al. · 2021 · PLoS ONE
Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer
Qingrong Li, Qiang Ma, Lei Xu, Chuanli Gao, Lihua Yao, Jilin Wen, Miyuan Yang, Jibing Cheng, Xi Zhou, Jiang Zou et al. · 2021 · Frontiers in Pharmacology
A Significance of Concomitant BRAF V600E and TERT Mutations in Polish Patients with Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Based on 430 Cases
Artur Kuchareczko, Janusz Kopczyński, Artur Kowalik, Kinga Hińcza, Agnieszka Walczyk, Iwona Pałyga, Tomasz Trybek, Monika Szymonek, Danuta Gąsior‐Perczak, Klaudia Gadawska‐Juszczyk et al. · 2022 · Thyroid
Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study
Zheng Ding, Xuanbin Tao, Xianzhao Deng, Bomin Guo, Jie Kang, Bo Wu, Zhili Yang, Chunyan Chen, Ping Liu, Yingchao Zhang et al. · 2023 · Journal of Cancer Research and Clinical Oncology
Prognostic value and immune landscapes of TERT promoter methylation in triple negative breast cancer
Fei Lin, Jiajia Huang, Wancui Zhu, Tongchao Jiang, Jia Guo, Wen Xia, Miao Chen, Ling Guo, Wuguo Deng, Huan‐Xin Lin · 2023 · Frontiers in Immunology
TERT promoter mutations: a genetic signature of benign and malignant thyroid tumours occurring in the context of tinea capitis irradiation
Paula Boaventura, Rui Batısta, Ana Pestana, M. Reis, Adélia Mendes, Catarina Eloy, Manuel A. Sobrinho-Simões, Paula Soares · 2016 · European Journal of Endocrinology
Telomerase Expression in a Series of Melanocytic Neoplasms
De Unamuno Bustos B, Sahuquillo Torralba A, Moles Poveda P, Pérez Simó G, Simarro Farinos J, Llavador Ros M, Palanca Suela S, Rafael Botella Estrada · 2019 · Actas Dermo-Sifiliográficas
Whole genome sequencing and its applications in medical genetics
Jiaxin Wu, Mengmeng Wu, Ting Chen, Rui Jiang · 2016 · Quantitative Biology
Heterogeneity of telomerase reverse transcriptase mutation and expression, telomerase activity and telomere length across human cancer cell lines cultured in vitro
Marta Dratwa, Barbara Wysoczańska, Eliza Turlej, Artur Anisiewicz, Magdalena Maciejewska, Joanna Wietrzyk, Katarzyna Bogunia‐Kubik · 2020 · Experimental Cell Research
Distinct transcriptional and prognostic impacts of TERT promoter mutations C228T and C250T in papillary thyroid carcinoma
Vicente Rodrigues Marczyk, Ana Luiza Maia, Iuri Martin Goemann · 2024 · Endocrine Related Cancer
Mechanistic basis of atypical TERT promoter mutations
Kerryn Elliott, Vinod Kumar Singh, Alan Bäckerholm, Linnea Ögren, Markus Lindberg, Katarzyna M. Soczek, Emily Hoberg, Tom Luijts, Jimmy Van den Eynden, Maria Falkenberg et al. · 2024 · Nature Communications
Molecular Characterization of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma
Jason C. Klein, Breelyn Ann Wilky, Heide L. Ford · 2025 · Cancers
High frequency of PIK3CA and TERT promoter mutations in fibromatosis-like spindle cell carcinomas
Siyuan Zhong, Shuling Zhou, Anqi Li, Hong Lv, Ming Li, Shaoxian Tang, Xiaoli Xu, Ruohong Shui, Wentao Yang · 2021 · Journal of Clinical Pathology
TERT Promoter Revertant Mutation Inhibits Melanoma Growth through Intrinsic Apoptosis
Yanbing Wang, Yiwu Chen, Chang Li, Zhiwei Xiao, Hongming Yuan, Yuanzhu Zhang, Daxin Pang, Xiaochun Tang, Mengjing Li, Hongsheng Ouyang · 2022 · Biology
A Nomogram for Predicting Early Recurrence in Patients with High-Grade Gliomas
Qing Zhou, Xiaoai Ke, Caiqiang Xue, Shenglin Li, Xiaoyu Huang, Bin Zhang, Junlin Zhou · 2022 · World Neurosurgery
Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Paulina Galka-Marciniak, Zuzanna Kanduła, Adrian Tire, Wladyslaw Wegorek, Kinga Gwóźdź, Luiza Handschuh, Maciej Giefing, Krzysztof Cezary Lewandowski, Piotr Kozłowski · 2022 · Scientific Reports
Molecular Pathological Characteristics of Thyroid Follicular-Patterned Tumors Showing Nodule-in-Nodule Appearance with Poorly Differentiated Component
Mayu Ueda, Katsuya Matsuda, Hirokazu Kurohama, Zhanna Mussazhanova, Yerkezhan Sailaubekova, Hisayoshi Kondo, Tomoki Shimizu, Nami Takada, Yuki Matsuoka, Chieko Otsubo et al. · 2022 · Cancers
Oncocytic thyroid neoplasms: from histology to molecular biology
Şule Canberk, Ana Rita Lima, Marcelo Correia, Rui Batısta, Paula Soares, Valdemar Máximo, Manuel A. Sobrinho-Simões · 2019 · Diagnostic histopathology
A review of predictive, prognostic and diagnostic biomarkers for brain tumours: towards personalised and targeted cancer therapy
Ernest K Osei, Pascale Walters, Olivia Masella, Quinton Tennant, Amber Fishwick, Eugenia Dadzie, Anmol Bhangu, Johnson Darko · 2019 · Journal of Radiotherapy in Practice
Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations
Kazutaka Otsuji, Takeshi Sasaki, Masahiko Tanabe, Yasuyuki Seto · 2020 · British Journal of Cancer
Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer
Rebecca F. Lowdon, Ting Wang · 2017 · PLoS ONE
Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia
Noemy Starita, Luigi Buonaguro, Franco M. Buonaguro, Maria Lina Tornesello · 2018 · Journal of Translational Medicine
Targeting oncogenic TERT promoter variants by allele-specific epigenome editing
Alexandra G. Kouroukli, Nivethika Rajaram, Pavel Bashtrykov, Helene Kretzmer, Reiner Siebert, Albert Jeltsch, Susanne Bens · 2023 · Clinical Epigenetics
Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks
Shengda Lin, Yi A. Yin, Xiaoqian Jiang, Nidhi Sahni, S. Stephen Yi · 2016 · BioMed Research International
Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma
Riming Liu, Yulan Li, Weixin Chen, Jianglin Cong, Zhengfang Zhang, Li Ma, Lina Chu, Hui Xiao, Yanhong Zhang, Yongming Liu et al. · 2020 · Oncology Letters
The impact of different negative training data on regulatory sequence predictions
Louisa-Marie Krützfeldt, Max Schubach, Martin Kircher · 2020 · PLoS ONE
Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
Jun Tae Park, Sungjoo Lee, Jiyun Park, Hyunju Park, Chang‐Seok Ki, Young-Lyun Oh, Jung-Hee Shin, Jee-Soo Kim, Sun‐wook Kim, Jae Hoon Chung et al. · 2021 · Cancers
Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes
Cristina Perez‐Becerril, D. Gareth Evans, Miriam Jane Smith · 2021 · Human Mutation
Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase
Songting Shou, Yuanliang Li, Jiaqin Chen, Xing Zhang, Chuanlong Zhang, Xiaochen Jiang, Fudong Liu, Yi Li, Xiyuan Zhang, En Geer et al. · 2024 · Cancer Gene Therapy
Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia
Regina Wan Ju Wong, Takashi Ishida, Takaomi Sanda · 2018 · Molecules
Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis
Chie Kikutake, Minako Yoshihara, Mikita Suyama · 2021 · NAR Cancer
Deep Learning Prediction of TERT Promoter Mutation Status in Thyroid Cancer Using Histologic Images
Jinhee Kim, Seokhwan Ko, Moonsik Kim, Ji Young Park, Hyung Soo Han, Junghwan Cho, Ji Young Park · 2023 · Medicina
Role of telomeres and telomerase in aging and cancer
Jerry W. Shay, Woodring Erik Wright, Roger Alan Schultz · 2003 · Garland Science eBooks
Identifying Driver Mutations in Cancer
Jack P. Hou, Jian Ma · 2013 · Translational bioinformatics
Telomerase Reverse Transcriptase Promoter Mutations in Human Hepatobiliary, Pancreatic and Gastrointestinal Cancer Cell Lines
Masahiro Hirata, Koji Fujita, Shintaro Fujihara, Takaaki Mizuo, Ryota Nakabayashi, TOSHIAKI KONO, Daisuke Namima, Naoki Fujita, Hiroki Yamana, Hideki Kamada et al. · 2021 · In Vivo
Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study
Maysam Alimohamadi, Amirhossein Larijani, Ahmad Pour‐Rashidi, Mostafa Farzin, Hannan Ebrahimi, Mohammad Rahmani, Kasra Hendi, Kourosh Karimi Yarandi, Sepehr Aghajanian, Mohammad Shirani · 2023 · World Neurosurgery
Performance of Urinary Markers in Patients With Suspicious Cystoscopy During Follow-up of Recurrent Non-muscle Invasive Bladder Cancer: BTA Stat, NMP22 BladderChek, UBC Rapid Test, CancerCheck UBC Rapid VISUAL, and Uromonitor in Comparison to Cytology
Thorsten Ecke, Christina J. Meisl, Thorsten Schlomm, Anja Rabien, Flora Labonté, Dezhi Rong, Sebastian L. Hofbauer, Frank Friedersdorff, Lilli Sommerfeldt, Nella Gagel et al. · 2024 · Urology
Therapeutic 6-thio-deoxyguanosine inhibits telomere elongation in cancer cells by inducing a non-productive stalled telomerase complex
Samantha L. Sanford, Mareike Badstübner, Michael H. Gerber, William P. Mannherz, Noah M. Lampl, Rachel L. Dannenberg, Angela M. Hinchie, Matthew A. Schaich, Sua Myong, Mark Hedglin et al. · 2025 · Nature Communications
Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter
Hui Shi, Le‐Hang Guo, Yifeng Zhang, Hui‐Jun Fu, Jiayi Zheng, Han-Xiang Wang, Chong‐Ke Zhao, Hui‐Xiong Xu · 2020 · Endocrine
Epstein–Barr virus induces morphological and molecular changes in thyroid neoplastic cells
Jacqueline Fátima Martins de Almeida, José Luiz Proença‐Módena, Natássia Elena Búfalo, Karina Colombera Peres, Elisângela de Souza Teixeira, Larissa Teodoro Rabi, Raíssa Marques Beck, Ana Paula Moraes, Álfio José Tincani, Clarice Weis Arns et al. · 2020 · Endocrine
Emerging systemic antitarget treatment for differentiated thyroid carcinoma
Neus Basté, Mireia Mora, Juan Jose Grau · 2021 · Current Opinion in Oncology
Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers
Paola Valeria Marchese, Veronica Mollica, Elisa Tassinari, Dario de Biase, Francesca Giunchi, Andrea Marchetti, Matteo Rosellini, Michelangelo Fiorentino, Francesco Massari · 2022 · Expert Review of Molecular Diagnostics
Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre‐operative identification of high‐risk cases
Martin Harper Hysek, L. Samuel Hellgren, Adam Stenman, Eva Darai‐Ramqvist, Elin Ljung, Igor Schliemann, Vincenzo Condello, Catharina Larsson, Jan Zedenius, Kenbugul Jatta et al. · 2023 · Diagnostic Cytopathology
TERTmonitor—qPCR Detection of TERTp Mutations in Glioma
João Paulo Brás, Tito T. Jesus, Hugo Prazeres, Jorge Pereira Lima, Paula Soares, João Vinagre · 2023 · Genes
Absence of TERT promoter mutations in pituitary adenomas
Clarissa Silva Martins, Margaret de Castro, Rodrigo T. Calado · 2016 · Journal of Endocrinological Investigation
The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
Alistair J. Rice, Armando E. del Río Hernández · 2019 · Frontiers in Oncology
Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all‐trans retinoic acid in cancer therapy
Delphine Garsuault, Claire Bouyer, Éric Nguyen, Rohan Kandhari, Martina Prochazkova‐Carlotti, Edith Chevret, Patricia Forgez, Evelyne Ségal‐Bendirdjian · 2020 · Molecular Oncology
Male patients with TERT mutation may be more likely to benefit from immunotherapy, especially for melanoma
Lee Jia, Zhaoyan Li, Chenyue Zhang, Chenxing Zhang, Haiyong Wang · 2020 · Aging
Molecular genetics of thyroid cancer
Maha Rebaï, Ahmed Rebaï · 2016 · Genetics Research
Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases
Shi Yang, Dominick A. Leone, Noah Frydenlund, Mai P. Hoang, April Deng, Marier Hernández‐Pérez, Asok Biswas, Rajendra Singh, Ron Yaar, Meera Mahalingam · 2016 · Melanoma Research
Copy Number Profiling of Brazilian Astrocytomas
Lucas Tadeu Bidinotto, Raul Torrieri, Alan G. Mackay, Gisele Caravina de Almeida, Marta Viana‐Pereira, Adriana Cruvinel‐Carloni, Maria Luisa Spina, Nathália Cristina Campanella, Weder Pereira de Menezes, Carlos Clara et al. · 2016 · G3 Genes Genomes Genetics
Study of hTERT and Histone 3 Mutations in Medulloblastoma
Marta Viana‐Pereira, Gisele Caravina de Almeida, João Norberto Stávale, Susana Malheiro, Carlos Clara, Patricia Rolim Mendonça Lôbo, José Pimentel, Rui Manuel Reis · 2016 · Pathobiology
Sequencing and curation strategies for identifying candidate glioblastoma treatments
Mayu O. Frank, Takahiko Koyama, Kahn Rhrissorrakrai, Nicolas Robine, Filippo Utro, Anne‐Katrin Emde, Bo‐Juen Chen, Kanika S. Arora, Minita J. Shah, Heather M. Geiger et al. · 2019 · BMC Medical Genomics
Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma
Tatsuya Hirokawa, Yuu Arimasu, Tomohiro Chiba, Masachika Fujiwara, Hiroshi Kamma · 2020 · Pathology International
RASAL1 in Thyroid Cancer: Wisdom From an Old Foe
Joanne Yuen Yie Ngeow, Charis Eng · 2013 · JNCI Journal of the National Cancer Institute